BB&T Securities LLC grew its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 228.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,568 shares of the company’s stock after buying an additional 3,871 shares during the period. BB&T Securities LLC’s holdings in Henry Schein were worth $456,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in HSIC. YorkBridge Wealth Partners LLC lifted its position in shares of Henry Schein by 5.2% in the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after buying an additional 28 shares during the last quarter. Sun Life Financial INC lifted its position in shares of Henry Schein by 8,185.7% during the 2nd quarter. Sun Life Financial INC now owns 580 shares of the company’s stock worth $106,000 after purchasing an additional 573 shares during the last quarter. FTB Advisors Inc. lifted its position in shares of Henry Schein by 100.0% during the 3rd quarter. FTB Advisors Inc. now owns 1,484 shares of the company’s stock worth $120,000 after purchasing an additional 742 shares during the last quarter. Trust Co. of Vermont lifted its position in shares of Henry Schein by 56.7% during the 3rd quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock worth $140,000 after purchasing an additional 616 shares during the last quarter. Finally, Lee Financial Co lifted its position in shares of Henry Schein by 100.0% during the 3rd quarter. Lee Financial Co now owns 1,756 shares of the company’s stock worth $144,000 after purchasing an additional 878 shares during the last quarter. 91.75% of the stock is owned by institutional investors.
In related news, Director Barry J. Alperin sold 5,796 shares of the business’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $70.76, for a total transaction of $410,124.96. Following the transaction, the director now directly owns 48,172 shares in the company, valued at $3,408,650.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.19% of the company’s stock.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.90 by ($0.03). Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The firm had revenue of $3.16 billion for the quarter, compared to the consensus estimate of $3.05 billion. During the same quarter in the prior year, the firm earned $0.84 earnings per share. The company’s revenue was up 10.3% on a year-over-year basis. equities analysts anticipate that Henry Schein, Inc. will post 3.6 EPS for the current fiscal year.
Henry Schein declared that its Board of Directors has initiated a stock repurchase plan on Monday, September 18th that permits the company to buyback $400.00 million in outstanding shares. This buyback authorization permits the company to repurchase up to 6.3% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s leadership believes its stock is undervalued.
Several equities analysts recently weighed in on the company. Deutsche Bank assumed coverage on Henry Schein in a research report on Friday. They set a “buy” rating and a $79.00 price objective for the company. Jefferies Group reissued a “hold” rating and set a $88.50 price objective on shares of Henry Schein in a research report on Thursday, September 28th. Stephens assumed coverage on Henry Schein in a research report on Tuesday, November 28th. They set an “equal weight” rating and a $76.00 price objective for the company. Leerink Swann reissued a “market perform” rating and set a $77.00 price objective (down previously from $87.50) on shares of Henry Schein in a research report on Tuesday, November 7th. Finally, Royal Bank Of Canada assumed coverage on Henry Schein in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $91.00 price objective for the company. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have assigned a buy rating to the company. Henry Schein presently has an average rating of “Hold” and a consensus price target of $87.79.
ILLEGAL ACTIVITY NOTICE: This report was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this report on another domain, it was stolen and republished in violation of international copyright law. The original version of this report can be read at https://stocknewstimes.com/2017/12/11/bbt-securities-llc-has-456000-holdings-in-henry-schein-inc-hsic.html.
Henry Schein Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.